The death-associated protein kinase (DAPK) is hypermethylated in drug-resistant derivatives generated from both non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC) cell lines (22). Here, DAPK1 is linked to head and neck squamous cell carcinoma.